Occult hepatitis B virus infection status is not associated with impaired efficacy of anti-CD19 CAR-T-cell therapy for lymphoma and shows a distinct immune toxicity profile: Results from the CART-SIE study. - Polverelli N; Chiappella A; Carniti C; Zinzani P; Musso M; Tisi MC; Ciceri F; Cutini I; Santoro A; Chiusolo P; Barbui AM; Farina M; et al. (HemaSphere, 2026)